July 9, 2026 01:50 PM EDT FDA criticizes Lundbeck for now-deleted webpages promoting its migraine treatment The FDA has chastised Lundbeck Seattle Biopharmaceuticals for two promotional webpages, neither of which is still online, that made allegedly inflated claims regarding the efficacy … Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.